DOCS Dermatology

Located in the US, DOCS Dermatology provides specialized dermatological services, focusing on skin health and aesthetic treatments across several states, ensuring comprehensive care for diverse patient needs. DOCS Dermatology specializes in dermatological care and was founded in 1978 in Blue Ash, US. In June 2022, the company was acquired by SkyKnight Capital and its management from Sheridan Capital Partners for USD 367 mn. The company has undertaken three deals to date.

DOCS Dermatology specializes in providing comprehensive dermatological care across multiple states, including Ohio, Michigan, Illinois, West Virginia, and Indiana. Their core offerings encompass a range of services aimed at diagnosing and treating skin conditions, conducting skin cancer screenings, and providing cosmetic dermatology solutions. The company's focus is on both medical and aesthetic treatments, addressing issues such as acne, eczema, psoriasis, and skin aging. Their services cater to a diverse clientele, including individual patients seeking skin care solutions as well as referrals from primary care physicians.

The company operates in specific geographical markets where the demand for dermatological services is significant, ensuring they meet the needs of both urban and suburban populations. DOCS Dermatology generates revenue primarily through direct patient transactions, which include consultations, treatment procedures, and cosmetic procedures. The company operates on a fee-for-service model where patients pay for individual treatments or procedures as needed. Their revenue structure is predominantly B2C, focusing on individual consumers who access services directly rather than through intermediaries.

Pricing plans vary based on the type of service rendered, with specific costs aligning with the complexity and nature of the treatment. Flagship services include advanced skin cancer screenings and popular cosmetic procedures that draw client interest, thereby contributing to the company's overall financial performance. Following the acquisition in June 2022, DOCS Dermatology plans to expand its market reach significantly. The funding from the acquisition will support initiatives aimed at expanding into additional states where there is rising demand for dermatological services.

Specific new markets are under consideration, with the company exploring opportunities to increase its physical presence and service offerings in these areas.